$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Growth hormone antagonists 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07K-013/00
  • C12P-021/06
  • A61K-037/36
출원번호 US-0878703 (1992-05-04)
발명자 / 주소
  • Kopchick John J. (Athens OH) Chen Wen Y. (Athens OH)
출원인 / 주소
  • Ohio University (Athens OH 02)
인용정보 피인용 횟수 : 358  인용 특허 : 0

초록

The present invention relates to antagonists of vertebrate growth hormones obtained by mutation of the third alpha helix of such proteins (especially bovine or human GHs). These mutants have growth inhibitory or other GH-antagonizing effects. These novel hormones may be administered exogenously to a

대표청구항

A vertebrate growth hormone in which the amino acid position in said vertebrate growth hormone corresponding to amino acid Gly 119 of bovine growth hormone is deleted or substituted with an amino acid, said vertebrate growth hormone having growth hormone antagonist activity.

이 특허를 인용한 특허 (358)

  1. McKerracher, Lisa; Munzer, Jon Scott, ADP-ribosyl transferase fusion variant proteins.
  2. Pramod B. Mahajan, Adenosine deaminase homologues and uses thereof.
  3. Bringhurst, F. Richard; Takasu, Hisashi; Gardella, Thomas J., Amino-terminal modified parathyroid hormone (PTH) analogs.
  4. Springer, Barry A.; Pantoliano, Michael W.; Sharp, Celia M., Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, Aspartate 101 or Leucine 137.
  5. Springer Barry A. ; Pantoliano Michael W. ; Sharp Celia M., Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137.
  6. Kakimoto, Tatsuo; Higuchi, Masayuki; Inoue, Tsutomu, Analysis of agonist-activity and antagonist-activity to cytokinin receptor.
  7. Martha Jo Whitehouse, Angiogenically effective unit dose of FGF-2 and method of use.
  8. Whitehouse, Martha Jo, Angiogenically effective unit dose of FGF-2 and method of use.
  9. Whitehouse,Martha J., Angiogenically effective unit dose of FGF-2 and method of use.
  10. Seehra, Jasbir; Knopf, John; Pearsall, Robert S.; Grinberg, Asya; Kumar, Ravindra, Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof.
  11. Center, David M.; Cruikshank, William W.; Kornfeld, Hardy, Antibodies against IL-16 antagonist peptides.
  12. Shi, Yanggu; Ruben, Steven M., Antibodies against interleukin 17 receptor-like protein.
  13. John Ford ; George Yeung, Antibodies specific for EGF motif proteins.
  14. Jacobs,Kenneth; Pittman,Debra D.; Fouser,Lynette; Spaulding,Vikki; Xuan,Dejun, Antibodies that bind to interleukin-22.
  15. Adams, Camellia W; Ashkenazi, Avi J; Chuntharapai, Anan; Kim, Kyung Jin, Antibodies to Apo-2 receptor polypeptides.
  16. Ruben, Steven M.; Rosen, Craig A.; Yu, Guo-Liang; Ni, Jian; Feng, Ping, Antibodies to HNFIP24 polypeptides.
  17. Rosen, Craig A.; Ruben, Steven M.; Moore, Paul A., Antibodies to HSDEK49 polypeptides.
  18. Rosen, Craig A.; Ruben, Steven M.; Zeng, Zhizhen, Antibodies to HTEEB42 protein.
  19. Ruben, Steven M.; Rosen, Craig A.; Wei, Ying-Fei, Antibodies to HWHGU54 polypeptides.
  20. Gill, Davinder S.; Li, Jing; Veldman, Geertruida M.; Fouser, Lynette A.; Valge-Archer, Viia; Lowe, David C.; Russell, Caroline S.; Cohen, Suzanne E.; Thom, Albert G.; Minter, Ralph R., Antibodies to human IL-22.
  21. Gill, Davinder S.; Li, Jing; Veldman, Geertruida M.; Fouser, Lynette A.; Valge-Archer, Viia; Lowe, David C.; Russell, Caroline S.; Cohen, Suzanne E.; Thom, Albert G.; Minter, Ralph R., Antibodies to human IL-22.
  22. Li, Haodong; Ruben, Steven M.; Sutton, III, Granger, Antibodies to human chemotactic protein.
  23. Ni,Jian; Rosen,Craig A.; Gentz,Reiner L., Antibodies to human tumor necrosis factor receptor-like 2.
  24. Ni,Jian; Li,Haodong; Yu,Guo Liang; Gentz,Reiner L., Antibodies to natural killer cell activating factor II.
  25. Theill, Lars Eyde; Yeh, Richard; Silbiger, Scott Michael; Yu, Gang; Senaldi, Giorgio, Antibody to TNF receptor-like molecules.
  26. Shi, Yanggu; Ruben, Steven M., Antibody to an IL-17 receptor like protein.
  27. Adams, Camellia W.; Ashkenazi, Avi J.; Chuntharapai, Anan; Kim, Kyung Jin, Apo-2 receptor agonist antibodies.
  28. Ashkenazi, Avi J., Apo-2 receptor polynucleotides.
  29. Ashkenazi, Avi J., Apo-2 receptor polypeptides.
  30. Amegadzie, Bernard; Cunningham, Mark; Dorai, Haimanti; Luo, Jeffrey; Mills, Juliane; Swencki-Underwood, Bethany, BMP-7 variant compositions, methods and uses.
  31. Seehra, Jasbir, BMP-ALK3 antagonists and uses for promoting bone growth.
  32. Seehra, Jasbir, BMP-ALK3 antagonists and uses for promoting bone growth.
  33. Shen, Wenyan; Tang, Jie; Wang, Yan; Matern, Hugo, Binding proteins and methods of use thereof.
  34. Gardella, Thomas J.; Kronenberg, Henry M.; Potts, John T.; Jüppner, Harald, Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP).
  35. Broekaert, Willem Frans; Cammue, Bruno Philippe Angelo; Osborn, Rupert William; Rees, Sarah Bronwen; Vanderleyden, Jozef, Biocidal proteins.
  36. Lee,Sang Kyou; Lee,Seung Kyou; Suh,Byung Fhy; Chae,Wook Jin; Kim,Jong Bum; Lee,Jong Sun; Yang,Jung Jin, Biomolecule transduction motif Sim-2-BTM and the use thereof.
  37. Discher, Dennis E.; Shin, Jae-Won, Bioreactor for isolation of rare cells and methods of use.
  38. Kandel, Eric R.; Santoro, Bina; Bartsch, Dusan; Siegelbaum, Steven; Tibbs, Gareth; Grant, Seth, Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof.
  39. Tudan,Christopher R.; Merzouk,Ahmed; Arab,Lakhdar; Saxena,Geeta; Eaves,Connie J.; Cashman,Johanne; Clark Lewis,Ian; Salari,Hassan, CXC chemokine receptor 4 agonist peptides.
  40. Tudan,Christopher R.; Merzouk,Ahmed; Arab,Lakhdar; Saxena,Geeta; Eaves,Connie J.; Cashman,Johanne; Richter, legal representative,Mary A.; Clark Lewis, legal representative,Michael; Salari,Hassan; Clark Lewis,Ian, CXCR4 antagonist treatment of hematopoietic cells.
  41. Sunagawa,Makoto; Sasaki,Akira; Hori,Seiji, Carbapenem compounds.
  42. Ni, Jian; Li, Haodong; Su, Jeffrey, Chemokine alpha 3.
  43. Martins-Green, Manuela; Feugate, Jo Ellen; Li, QiJing, Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts.
  44. Jacobs, Kenneth; Pittman, Debra D.; Fouser, Lynette; Spaulding, Vikki; Xuan, Dejun, Composition and method for treating inflammatory disorders.
  45. Coughlan, Sean J., Compositions and methods for altering an acetyl-CoA metabolic pathway of a plant.
  46. Rossomando, Anthony; Silvestre, Jean-Sebastien; Tamarat, Radia, Compositions and methods for increasing vascularization.
  47. Wang, Tongtong; Henderson, Robert A.; Foy, Teresa M., Compositions and methods for the therapy and diagnosis of lung cancer.
  48. Wang, Tongtong; Henderson, Robert A.; Foy, Teresa M., Compositions and methods for the therapy and diagnosis of lung cancer.
  49. Valdez,Patricia A.; Gurney,Austin L.; Grewal,Iqbal, Compositions and methods for the treatment of immune related diseases.
  50. Behrens, Dirk; Bosch, Elizabeth; Doberstein, Stephen K.; Halenbeck, Robert Forgan; Hestir, Kevin; Huang, Min Mei; Lee, Ernestine; Lin, Haishan; Linnemann, Thomas; Marshall, Shannon; Wong, Justin G. P.; Wu, Ge; Zhou, Aileen; Leo, Cindy; Williams, Lewis T., Compositions and methods of use for MGD-CSF in disease treatment.
  51. Behrens, Dirk; Bosch, Elizabeth; Doberstein, Stephen K.; Halenbeck, Robert Forgan; Hestir, Kevin; Huang, Min Mei; Lee, Ernestine; Lin, Haishan; Linnemann, Thomas; Marshall, Shannon; Wong, Justin G. P.; Wu, Ge; Zhou, Aileen; Leo, Cindy; Williams, Lewis T., Compositions and methods of use for MGD-CSF in disease treatment.
  52. Lindhout, Darrin Anthony; Haldankar, Raj; Tian, Hui; Hsu, Jer-Yuan, Compositions and methods of use for treating metabolic disorders.
  53. Lindhout, Darrin Anthony; Zhang, Peng; Parsons, Thomas Frederick, Compositions and methods of use for treating metabolic disorders.
  54. Matern, Hugo; Lindhout, Darrin Anthony; Haldankar, Raj, Compositions and methods of use for treating metabolic disorders.
  55. Matern, Hugo; Lindhout, Darrin Anthony; Haldankar, Raj; Horner, Geoffrey, Compositions and methods of use for treating metabolic disorders.
  56. Shen, Wenyan; Lindhout, Darrin Anthony; Haldankar, Raj; Matern, Hugo, Compositions and methods of use for treating metabolic disorders.
  57. Grinberg, Asya; Knopf, John; Pearsall, Robert S.; Kumar, Ravindra; Seehra, Jasbir; Pietras, Kristian, Compositions comprising ALK1-ECD protein.
  58. Packham,Keith Graham; Reed,Michael John; Potter,Barry Victor Lloyd, Compositions comprising oestrone-3-0-sulphamate and trail (TNF-related apoptosis inducing ligand).
  59. Chu,Chung K.; Cheng,Yung Chi, Compounds and methods for the treatment of cancer.
  60. Gardella, Thomas J.; Shimizu, Naoto; Kronenberg, Henry M.; Potts, Jr., John T., Conformationally constrained parathyroid hormone (PTH) analogs.
  61. Gardella, Thomas J.; Potts, Jr., John T.; Kronenberg, Henry M.; Shimizu, Naoto, Conformationally constrained parathyroid hormones with alpha-helix stabilizers.
  62. Kieliszewski, Marcia J.; Held, Michael; Tan, Li, Cross-linkable glycoproteins and methods of making the same.
  63. Ni, Jian; Yu, Guo-Liang; Gentz, Reiner L., Cytostatin II.
  64. Ni,Jian; Yu,Guo Liang; Gentz,Reiner L., Cytostatin II antibodies and methods.
  65. Friedman,Jeffrey M.; Lee,Gwo Hwa; Proenca,Ricardo, DB, the receptor for leptin.
  66. Parham,Christi L.; Moore,Kevin W.; Murgolo,Nicholas J.; Bazan,J. Fernando, DIRS1 antibodies.
  67. Parham, Christi L.; Moore, Kevin W.; Murgolo, Nicholas J.; Bazan, J. Fernando, DIRS1 polypeptides.
  68. Jian Ni ; Haodong Li ; Guo-Liang Yu ; Reiner L. Gentz, DNA encoding human natural killer cell activating factor II.
  69. Papadopoulos,Vassilios; Li,Hua, DNA encoding peripheral-type benzodiazipine receptor associated protein 7 and applications or methods of use.
  70. Snapir, Amir; Heinonen, Paula; Alhopuro, Pia; Karvonen, Matti; Koulu, Markku; Pesonen, Ullamari; Scheinin, Mika; Salonen, Jukka T.; Tuomainen, Tomi-Pekka; Lakka, Timo A.; Nyyssonen, Kristiina; Salone, DNA molecule encoding a variant α2B-adrenoceptor protein, and uses thereof.
  71. Lovenberg,Timothy; Liu,Changlu, DNAs encoding guinea pig histamine receptors of the H4 subtype.
  72. Lovenberg,Timothy; Liu,Changlu, DNAs encoding mammalian histamine receptor of the H4 subtype and encoded protein.
  73. Lovenberg,Timothy; Liu,Changlu, DNAs encoding rat histamine receptors of the H4 subtype.
  74. Yu, Guo-Liang; Ni, Jian; Gentz, Reiner L.; Dillon, Patrick J., DR3 antibodies.
  75. Yu, Guo-Liang; Ni, Jian; Dixit, Vishva M.; Gentz, Reiner L.; Dillon, Patrick J., Death domain containing receptors.
  76. Yu,Guo Liang; Ni,Jian; Gentz,Reiner L.; Dillon,Patrick J., Death domain containing receptors.
  77. Wallach, David; Ramakrishnan, Parameswaran; Shmushkovich, Taisia, Derivatives of the IL-2 receptor gamma chain, their production and use.
  78. Wallach,David; Ramakrishnan,Parameswaran; Shmushkovich,Taisia, Derivatives of the IL-2 receptor gamma chain, their production and use.
  79. John Ford ; George Yeung, EGF MOTIF protein obtained from a cDNA library of fetal liver-spleen.
  80. Coleman, Timothy A.; Rosen, Craig A., Endothelial-monocyte activating polypeptide III.
  81. Coleman,Timothy A.; Rosen,Craig A.; Olsen,Henrik S., Endothelial-monocyte activating polypeptide III.
  82. Coleman,Timothy A.; Rosen,Craig A., Endothelial-monocyte activating polypeptide III antibodies.
  83. Murray, Samuel S.; Murray, Elsa J.; Wang, Jeffrey; Behnam, Keyvan, Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP).
  84. Coco,Wayne M.; Pienkos,Philip P.; Loomis,A. Katrina, Epidermal growth factor agonists.
  85. Umansky, Samuil; Melkonyan, Hovsep, Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof.
  86. Becker, Gerald Wayne; Cohen, Fredric Jay; Gonzalez-DeWhitt, Patricia Ann; Hale, John Edward; Micanovic, Radmila; Newton, Christy Michelle; Noblitt, Timothy Wayne; Rathnachalam, Radhakrishnan; Tschang, Flint polypeptide analogs.
  87. Hays, Anna-Maria A.; Buechler, Ying; Litzinger, David C., Formulations of human growth hormone comprising a non-naturally encoded amino acid.
  88. Hays, Anna-Maria; Buechler, Ying; Litzinger, David C., Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35.
  89. Takahashi,Yasuhiko; Matsumoto,Yasuo; Oeda,Kenji, G proteins, polynucleotide encoding the same and utilization thereof.
  90. Levetan, Claresa, Generation of new pancreatic beta cells.
  91. Fisher, Paul B.; Magdalena, Leszczyniecka, Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof.
  92. Se-Jin Lee ; Thanh Huynh ; Suzanne Sebald, Growth differentiation factor, lefty-1.
  93. Lee, Se-Jin; Huynh, Thanh; Sebald, Suzanne, Growth differentiation factor, lefty-2.
  94. Lee,Se Jin; Huynh,Thanh; Sebald,Suzanne, Growth differentiation factor, lefty-2.
  95. Se-Jin Lee ; Thanh Huynh ; Suzanne Sebald ; Christopher Rankin ; Edward Hsiao, Growth differentiation factor-15.
  96. Lee,Se Jin; McPherron,Alexandra C., Growth differentiation factor-8.
  97. Se-Jin Lee ; Alexandra C. McPherron, Growth differentiation factor-8 family nucleic acid sequences.
  98. Harari, Daniel; Yarden, Yosef, Growth factor which acts through ErbB-4 RTK.
  99. Harari,Daniel; Yarden,Yosef, Growth factor which acts through erb b-4 rtk.
  100. James A. Wells ; Brian C. Cunningham, Growth hormone variants.
  101. Wells, James A.; Cunningham, Brian C., Growth hormone variants.
  102. Wells, James A.; Cunningham, Brian C., Growth hormone variants.
  103. Bass Steven H. (Redwood City CA) Greene Ronald (Durham NC) Lowman Henry B. (Hercules CA) Wells James A. (Burlingame CA), Growth hormone variants with altered binding properties.
  104. Kopchick,John Joseph, Growth hormone-regulatable brown adipose tissue genes and proteins and uses thereof.
  105. Kopchick, John Joseph; Tiong, Jean, Growth hormone-regulatable liver genes and proteins, and uses thereof.
  106. Kopchick,John Joseph; Tiong,Jean, Growth hormone-regulatable liver genes and proteins, and uses thereof.
  107. Hafen,Ernst; Stocker,Hugo; Daram,Pierre; Shindelholz,Benno; Breuer,Sebastian, Growth regulating proteins.
  108. Rosen, Craig A.; Ruben, Steven M., HWBAO62 polypeptides.
  109. Tadahiko Yoshima JP; Hideki Yanagi JP; Takashi Yura JP, Heat shock transcription factor-binding protein.
  110. Hiraoka, Atsunobu; Sugimura, Atsushi; Mio, Hiroyuki, Hematopoietic stem cell growth factor (SCGF).
  111. Pecker,Iris; Vlodavsky,Israel; Friedman,Yael; Perets,Tuvia, Heparanase specific antibodies and their use in research and medical applications.
  112. Pecker, Iris; Vlodavsky, Israel; Friedmann, Yael; Peretz, Tuvia, Heparanase specific molecular probes and their use in research and medical applications.
  113. Christer Owman SE, Heptahelix receptor and its use.
  114. Rennert, Paul; Thompson, Jeffrey S.; Ambrose, Christine; Cachero, Teresa G., Heterologous polypeptide of the TNF family.
  115. Ni Jian ; Yu Guo-Liang ; Gentz Reiner ; Dillon Patrick J., Human 4-1BB receptor splicing variant.
  116. Hardiman, Gerard T.; Rock, Fernando L.; Bazan, J. Fernando; Kastelein, Robert A.; Ho, Stephen W. K.; Liu, Yong-Jun, Human DNAX toll-like receptor 4 proteins, related reagents and methods.
  117. Jacobs, Kenneth; Fouser, Lynette; Spaulding, Vikki; Xuan, Dejun, Human GIL-19/AE289 polynucleotides and methods of producing the encoded polypeptides.
  118. Jacobs, Kenneth; Fouser, Lynette; Spaulding, Vikki; Xuan, Dejun, Human GIL-19/AE289 proteins.
  119. Jacobs,Kenneth; Fouser,Lynette; Spaulding,Vikki; Xuan,Dejun, Human GIL-19/AE289 proteins.
  120. Jacobs,Kenneth; Fouser,Lynette; Spaulding,Vikki; Xuan,Dejun, Human Gil-19/AE289 polynucleotides.
  121. He,Wei Wu; Carter,Kenneth C., Human NK-3 related prostate specific gene-1.
  122. Haodong Li ; Steven M. Ruben ; Granger Sutton, III, Human chemotactic protein.
  123. Cho, Ho Sung; Daniel, Thomas O.; DiMarchi, Richard D.; Hays, Anna-Maria; Wilson, Troy E.; Sim, Bee-Cheng; Litzinger, David C., Human growth hormone modified at position 35.
  124. Cunningham Brian C. ; Wells James A., Human growth hormone variant having enhanced affinity for human growth hormone receptor at site 1.
  125. Cunningham Brian C. ; Lowman Henry ; Wells James A., Human growth hormone variants.
  126. Cunningham Brian C. ; Lowman Henry B. ; Wells James A. ; Clark Ross G. ; Olson Kenneth ; Fuh Germaine G., Human growth hormone variants.
  127. Cunningham Brian C. ; Wells James A. ; Clark Ross G. ; Olson Kenneth ; Fuh Germaine G., Human growth hormone variants comprising amino acid substitutions.
  128. Cunningham Brian C. ; Lowman Henry ; Wells James A., Human growth hormone variants having enhanced affinity for human growth hormone receptor at site 1.
  129. Jennifer L. Hillman ; Surya K. Goli, Human pancreatitis-associated protein.
  130. Bringhurst,F. Richard; Takasu,Hisashi; Gardella,Thomas J.; Potts, Jr.,John T., Human parathyroid hormone modifications, preparation and use.
  131. Bumcrot, David A., Human patched genes and proteins, and uses related thereto.
  132. Hardiman,Gerard T.; Rock,Fernando L.; Bazan,J. Fernando; Kastelein,Robert A.; Ho,Stephen W. K.; Liu,Yong Jun, Human receptor proteins; related reagents and methods.
  133. Schneider Fresenius, Christian; Otto, Bernd; Waschütza, Gero, Human recombinant beta-interferon with improved solubility.
  134. Schneider Fresenius,Christian; Otto,Bernd; Wasch체tza,Gero, Human recombinant beta-interferon with improved solubility.
  135. Ni,Jian; Rosen,Craig A.; Gentz,Reiner L.; Lyn,Sally Doreen Patricia; Hurle,Mark Robert, Human tumor necrosis factor receptor-like 2.
  136. Ni, Jian; Baker, Kevin P.; Ruben, Steven M.; Young, Paul E., Human tumor necrosis factor receptors TR13 and TR14.
  137. Dubin,Adrienne Elizabeth; Huvar,Arne; Glass,Charles A.; Erlander,Mark G., Human vanilloid receptor VR3 protein.
  138. Center, David M.; Cruikshank, William W.; Kornfeld, Hardy, IL-16 antagonist peptides and DNA encoding the peptides.
  139. Center,David M.; Cruikshank,William W.; Kornfeld,Hardy, IL-16 antagonist peptides and DNA encoding the peptides.
  140. Center,David M.; Cruikshank,William W.; Kornfeld,Hardy, IL-16 antagonists.
  141. Benson, Jacqueline; Cunningham, Mark; Luo, Jeffrey (Sinquan), IL-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses.
  142. Lauder, Scott; Gillies, Stephen D., IL-7 fusion proteins.
  143. Lauder,Scott; Gillies,Stephen D., IL-7 fusion proteins.
  144. Fagan,Richard; Phelps,Christopher Benjamin; Davies,Mark Douglas; Power,Christine, IL-8 like protein.
  145. Kedl,Ross M.; Griesgraber,George W.; Zarraga,Isidro Angelo E.; Wightman,Paul D., Immunostimulatory compositions and methods of stimulating an immune response.
  146. Nebolsin, Vladimir Evgenievich; Gorbunova, Vera Andreevna; Treschalin, Ivan Dmitrievich; Raikhlin, Natan Tanfelevich; Garin, Avgust Mikhailovich; Bychkov, Mark Borisovich; Treschalina, Elena Mikhailovna; Zheltukhina, Galina Alexandrovna, Induction method for cell differentiation.
  147. Tarasova, Nadya I.; Michejda, Christopher J.; Gottesman, Michael M.; Hrycyna, Christine A., Inhibition of ABC transporters by transmembrane domain analogs.
  148. Hillman, Jennifer L.; Corley, Neil C.; Guegler, Karl J.; Baughn, Mariah, Insulin receptor tyrosine kinase substrate.
  149. Yanggu Shi ; Steve M. Ruben, Interleukin 17-like receptor protein.
  150. Terman, David S., Intrathecal and intratumoral superantigens to treat malignant disease.
  151. Anderson, Dirk M.; Galibert, Laurent J., Isolated DNA molecule encoding rank ligand.
  152. Lesage,Florian; Guillemare,Eric; Fink,Michel; Duprat,Fabrice; Lazdunski,Michel; Romey,Georges; Barhanin,Jacques, Isolated TWIK-1 potassium channel proteins.
  153. Masure, Stefan Leo Jozef, Isolated nucleic acid molecule encoding a neurotrophic growth factor.
  154. Gospodarowicz,Denis J.; Kavanaugh,W. Michael; Crawford,Kenneth, KGF polypeptide compositions.
  155. Ruben Steven M. ; Jimenez Pablo ; Duan D. Roxanne ; Rampy Mark A. ; Mendrick Donna ; Zhang Jun ; Ni Jian ; Moore Paul A. ; Coleman Timothy A. ; Gruber Joachim R. ; Dillon Patrick J. ; Gentz Reiner L., Keratinocyte growth factor-2.
  156. Ruben, Steven M.; Jimenez, Pablo; Duan, D. Roxanne; Rampy, Mark A.; Mendrick, Donna; Zhang, Jun; NI, Jian; Moore, Paul A.; Coleman, Timothy A.; Gruber, Joachim R.; Dillon, Patrick J.; Gentz, Reiner L, Keratinocyte growth factor-2.
  157. Ruben, Steven M.; Jimenez, Pablo; Duan, D. Roxanne; Rampy, Mark A.; Mendrick, Donna; Zhang, Jun; Ni, Jian; Moore, Paul A.; Coleman, Timothy A.; Gruber, Joachim R.; Dillon, Patrick J.; Gentz, Reiner L, Keratinocyte growth factor-2.
  158. Ruben, Steven M.; Jimenez, Pablo; Duan, D. Roxanne; Rampy, Mark A.; Mendrick, Donna; Zhang, Jun; Ni, Jian; Moore, Paul A.; Coleman, Timothy A.; Gruber, Joachim R.; Dillon, Patrick J.; Gentz, Reiner L, Keratinocyte growth factor-2.
  159. Gentz Reiner L. ; Chopra Arvind ; Kaushal Parveen ; Spitznagel Thomas ; Unsworth Edward ; Khan Fazel, Keratinocyte growth factor-2 formulations.
  160. Gentz, Reiner L.; Chopra, Arvind; Kaushal, Parveen; Spitznagel, Thomas; Unsworth, Edward; Khan, Fazal, Keratinocyte growth factor-2 formulations.
  161. Gentz, Reiner L.; Chopra, Arvind; Kaushal, Parveen; Spitznagel, Thomas; Unsworth, Edward; Khan, Fazal, Keratinocyte growth factor-2 formulations.
  162. Ruben,Steven M.; Gruber,Joachim R.; Duan,D. Roxanne; Rampy,Mark A.; Mendrick,Donna; Zhang,Jun; Ni,Jian; Moore,Paul A.; Coleman,Timothy A.; Dillon,Patrick J.; Gentz,Reiner L.; Jimenez,Pablo, Keratinocyte growth factor-2 polynucleotides.
  163. Narhi, Linda Owers; Osslund, Timothy David, Keratinocyte growth factor-2 products.
  164. Shi, Yanggu; Ruben, Stephen M., Kit comprising an antibody to interleukin 17 receptor-like protein.
  165. Bihain,Bernard; Bougueleret,Lydie; Yen Potin,Frances, LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications.
  166. Joel S. Hayflick, Lectomedin materials and methods.
  167. Germaine Fuh ; James A. Wells, Ligand antagonists for treatment of breast cancer.
  168. Mori, Masaaki; Shimomura, Yukio; Harada, Mioko; Asami, Taiji; Matsumoto, Yoshio; Adachi, Yuka; Sugo, Tsukasa; Abe, Michiko; Goto, Mika; Kitada, Chieko; Watanabe, Takuya, Ligand to GPR8.
  169. Bakker,Alexander B. H.; Phillips,Joseph H.; Lanier,Lewis L., MDL-1 polypeptides.
  170. Miyata,Toshio, MEGSIN protein.
  171. Hastings,Gregg A.; Jonak,Zdenka L.; Trulli,Stephen H.; Fornwald,James A.; Terrett,Jonathan A., METH1 polynucleotides.
  172. Dhugga, Kanwarpal S.; Wang, Xun; Bowen, Benjamin A., Maize nucleic acid encoding a GDP-mannose pyrophosphorylase.
  173. Hedrick,Joseph A.; Sana,Theodore R.; Bazan,J. Fernando; Kastelein,Robert A., Mammalian cytokines; related reagents and methods.
  174. Preeti Lal ; Y. Tom Tang ; Mariah R. Baughn ; Matthew R. Kaser, Mammalian imidazoline receptor.
  175. Ptacek, Louis J.; White, H. Steve; Fu, Ying-Hui; Skradski, Shana, Mass1 gene, a target for anticonvulsant drug development.
  176. Polston,Jane E.; Hiebert,Ernest; Abouzid,Ahmed M.; Hunter,Wayne B., Materials and methods for producing geminivirus resistant plants.
  177. Kakimoto, Tatsuo; Higuchi, Masayuki; Inoue, Tsutomu, Method for determining antagonist activity to a cytokinin receptor.
  178. Gosling,Jennifa; Dairaghi,Daniel J.; Hanley,Michael; Miao,Zhenhua; Talbot,Dale; Schall,Thomas J., Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine.
  179. James A. Wells ; Brian C. Cunningham, Method for identifying active domains and amino acid residues in polypeptides and hormone variants.
  180. Wells James A. ; Cunningham Brian C., Method for identifying active domains and amino acid residues in polypeptides and hormone variants.
  181. Wells James A. ; Cunningham Brian C., Method for identifying active domains and amino acid residues in polypeptides and hormone variants.
  182. Sacha Holland CA; Geraldine Mbamalu CA; Tony Pawson CA, Method for identifying compounds that inhibit or enhance activation of a transmembrane ligand for a receptor tyrosine kinase.
  183. Cunningham Brian C. ; Lowman Henry B. ; Wells James A. ; Clark Ross G. ; Olson Kenneth ; Fuh Germaine G., Method for inhibiting growth hormone action.
  184. Cunningham Brian C. ; Wells James A. ; Clark Ross G. ; Olson Kenneth ; Fuh Germaine G., Method for inhibiting growth hormone action.
  185. Hauptmann,Rudolf; Himmler,Adolf; Maurer Fogy,Ingrid; Stratowa,Christian, Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF.
  186. Sano,Yorikata; Inamura,Kohei; Miyake,Akira; Yokoi,Hiromichi; Nozawa,Katsura; Mochizuki,Shinobu, Method of screening cell death inhibitor.
  187. Day, Anthony; Milner, Caroline; Drummond, Sheona Patricia, Method of treating bone disorders using TSG-6.
  188. Sabokbar, Afsie; Day, Anthony; Milner, Caroline, Method of treating bone disorders using TSG-6.
  189. Whitehouse, Martha Jo, Method of treating coronary artery disease FGF-2.
  190. Martha J. Whitehouse ; W. Michael Kavanaugh, Method of treating coronary artery disease by administering a recombinant FGF.
  191. Dinarello, Charles A; Kim, Soo-Hyun; Bufler, Philip, Method of treatment using a cytokine able to bind IL-18BP to inhibit the activity of a second cytokine.
  192. Dinarello,Charles A.; Kim,Soo Hyun; Bufler,Philip, Method of treatment using a cytokine able to bind IL-18BP to inhibit the activity of a second cytokine.
  193. Latov, Norman; Lee, Grace, Method to treat autoimmune demyelinating diseases and other autoimmune or inflammatory diseases.
  194. Garcia, Joe G. N., Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases.
  195. Tang,Y. Tom, Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides.
  196. Doi, Toshio; Abe, Hideharu, Methods for detecting diabetic nephropathy comprising measuring the expression of Smad1.
  197. Ciossek,Thomas; Ullrich,Axel; Millauer,Birgit, Methods for diagnosis and treatment of MDK1 signal transduction disorders.
  198. Buechler, Ying; Lieu, Ricky; Ong, Michael; Bussell, Stuart; Knudsen, Nick; Cho, Ho Sung, Methods for expression and purification of recombinant human growth hormone.
  199. Gosling,Jennifa; Dairaghi,Daniel J.; Hanley,Michael; Miao,Zhenhua; Schall,Thomas J., Methods for identifying modulators of CCX CKR activity.
  200. Rossomando, Anthony; Silvestre, Jean-Sebastien; Tamarat, Radia, Methods for increasing vascularization.
  201. Reiter, Robert E; Witte, Owen N, Methods for inhibiting the growth of cancer cells expressing PSCA.
  202. Kleinberg, David L.; Vidal, Sergio; Ruan, Weifeng, Methods for treating benign prostatic hypertrophy (BPH).
  203. Ni,Jian; Li,Haodong; Su,Jeffrey Y., Methods of making chemokine alpha 3 antibodies.
  204. Ganesh Madhusudan Sathe ; Wendy S Halsey ; Jon Chambers GB; Alison Muir GB; Philip Szekeres GB, Methods of screening for agonists and antagonists of the HNEAA81 receptor.
  205. Clark Lewis,Ian; Gong,Jiang Hong; Duronio,Vincent; Salari,Hassan, Methods of treating autoimmune diseases comprising administering CXCR4 antagonists.
  206. Lee, Se Jin; McPherron, Alexandra C., Methods of treating musculodegenerative disease with an antibody that binds growth differentiation factor-8.
  207. Masure, Stefano Leo Jozef, Methods of treating neuropathic pain with an environ polypeptide.
  208. Springer,Barry A.; Pantoliano,Michael W.; Sharp,Celia M., Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137.
  209. Springer, Barry A.; Pantoliano, Michael W.; Sharp, Celia M., Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, aspartate 101 or leucine 137.
  210. Fouser, Lynette A.; Hegen, Martin; Luxenberg, Deborah P.; O'Toole, Margot, Methods of using antibodies against human IL-22.
  211. Fouser, Lynette A.; Hegen, Martin; Luxenberg, Deborah P.; O'Toole, Margot, Methods of using antibodies against human IL-22.
  212. Fouser, Lynette; O'Toole, Margot; Luxenberg, Deborah P.; Hegen, Martin, Methods of using antibodies against human IL-22.
  213. Kreider, Brent L.; Ruben, Steven M.; Olsen, Henrik S, Methods of using chemokine beta-6.
  214. Wolfman, Neil M.; Khor, Soo Peang; Tomkinson, Kathleen N., Modified and stabilized GDF propeptides and uses thereof.
  215. Wolfman, Neil M.; Khor, Soo-Peang; Tomkinson, Kathleen N., Modified and stabilized GDF propeptides and uses thereof.
  216. Wolfman,Neil M.; Khor,Soo Peang; Tomkinson,Kathleen N., Modified and stabilized GDF propeptides and uses thereof.
  217. Kangawa, Kenji; Kojima, Masayasu; Hosoda, Hiroshi; Matsuo, Hisayuki; Minamitake, Yoshiharu, Modified gherlin peptides.
  218. Kangawa, Kenji; Kojima, Masayasu; Hosoda, Hiroshi; Matsuo, Hisayuki; Minamitake, Yoshiharu, Modified gherlin peptides.
  219. Kangawa, Kenji; Kojima, Masayasu; Hosoda, Hiroshi; Matsuo, Hisayuki; Minamitake, Yoshiharu, Modified ghrelin peptides.
  220. Kangawa, Kenji; Kojima, Masayasu; Hosoda, Hiroshi; Matsuo, Hisayuki; Minamitake, Yoshiharu, Modified ghrelin peptides.
  221. Kangawa,Kenji; Kojima,Masayasu; Hosoda,Hiroshi; Matsuo,Hisayuki; Minamitake,Yoshiharu, Modified ghrelin polypeptides.
  222. Guyon, Thierry; Borrelly, Gilles; Drittanti, Lila; Vega, Manuel, Modified growth hormone.
  223. Guyon, Thierry; Borrelly, Gilles; Drittanti, Lila; Vega, Manuel, Modified growth hormones.
  224. Guyon, Thierry; Borrelly, Gilles; Drittanti, Lila; Vega, Manuel, Modified growth hormones that exhibit increased protease resistance and pharmaceutical compositions thereof.
  225. Cho, Ho Sung; Daniel, Thomas O.; DiMarchi, Richard D.; Hays, Anna-Maria A.; Wilson, Troy E.; Sim, Bee-Cheng; Litzinger, David C., Modified human growth hormone.
  226. Hays, Anna-Maria; Buechler, Ying; Litzinger, David C., Modified human growth hormone formulations with an increased serum half-life.
  227. F. Richard Bringhurst ; Hisashi Takasu JP; Thomas J. Gardella ; John T. Potts, Jr., Modified human parathyroid hormone.
  228. Feige,Ulrich, Modified peptides as therapeutic agents.
  229. Wallach, David; Boldin, Mark; Goncharov, Tanya; Golstev, Yury V., Modulators of the function of FAS receptors and other proteins.
  230. Wallach, David; Boldin, Mark; Goncharov, Tanya; Golstev, Yury V., Modulators of the function of FAS receptors and other proteins.
  231. Li, Jing; Tan, Xiang Yang; Tomkinson, Kathleen N.; Pittman, Debra D.; Veldman, Geertruida M.; Fouser, Lynette, Monoclonal antibodies against interleukin-22.
  232. Chen, Wen Yuan, Multimeric ligands with enhanced stability.
  233. Chihara Kazuo,JPX, Mutant human growth hormones and their uses.
  234. Ni,Jian; Li,Haodong; Yu,Guo Liang; Gentz,Reiner L., Natural killer cell activating factor II.
  235. Bamber,Bruce A.; Jorgensen,Erik M., Nematode neuromuscular junction GABA receptors and methods related thereto.
  236. Bruce A. Bamber ; Erik M. Jorgensen, Nematode neuromuscular junction GABA receptors and methods related thereto.
  237. Bamber,Bruce A.; Jorgensen,Erik M., Nematode neuromuscular junction GABA receptors subunits.
  238. Rossomando, Anthony; Silvian, Laura; Pepinsky, R. Blake, Neublastin variants.
  239. Sah, Dinah W. Y.; Johansen, Teit E.; Rossomando, Anthony, Neurotrophic factors and methods of use thereof.
  240. Masure,Stefan Leo Jozef, Neurotrophic growth factor.
  241. Masure, Stefan Leo Jozef, Neurotrophic growth factor, enovin.
  242. Challita Eid, Pia M.; Raitano, Arthur B.; Faris, Mary; Hubert, Rene S.; Morrison, Karen Jane Meyrick; Morrison, Robert Kendall; Ge, Wangmao; Jakobovits, Aya, Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer.
  243. Challita-Eid, Pia M.; Raitano, Arthur B.; Faris, Mary; Hubert, Rene S.; Morrison, Karen Jane Meyrick; Morrison, Robert Kendall; Ge, Wangmao; Jakobovits, Aya, Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer.
  244. Challita-Eid, Pia M.; Raitano, Arthur B.; Faris, Mary; Hubert, Rene S.; Morrison, Karen Jane Meyrick; Morrison, Robert Kendall; Ge, Wangmao; Jakobovits, Aya, Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer.
  245. Gill, Davinder S.; Li, Jing; Veldman, Geertruida M.; Fouser, Lynette A.; Valge-Archer, Viia; Lowe, David C.; Russell, Caroline S.; Cohen, Suzanne E.; Thom, Albert G.; Minter, Ralph R., Nucleic acid encoding antibody to human IL-22.
  246. Kieliszewski, Marcia J.; Xu, Jianfeng; Meyer, Gary D., Nucleic acid for plant expression of a fusion protein comprising hydroxyproline O-glycosylation glycomodule.
  247. Lu,Peter S.; Garman,Jonathan David; Candia, III,Albert Frederick, Nucleic acid molecule encoding a CLASP-2 transmembrane protein.
  248. Kwon, Byoung S., Nucleic acid molecules encoding human 4-1BB.
  249. Friedman,Jeffrey M.; Lee,Gwo Hwa; Proenca,Ricardo, Nucleic acids db, the receptor for leptin.
  250. Theill,Lars Eyde; Yeh,Richard; Silbiger,Scott Michael; Yu,Gang; Senaldi,Giorgio, Nucleic acids encoding MK61 receptors.
  251. Christer Owman SE, Nucleic acids encoding a heptahelix receptor, and methods of using them.
  252. Goddard,Audrey; Pan,James; Yan,Minhong, Nucleic acids encoding a tumor necrosis factor homolog.
  253. Paul O. Sheppard ; Stephen R. Jaspers ; Zeren Gao, Nucleic acids encoding connective tissue growth factor homologs.
  254. Bringhurst, F. Richard; Takasu, Hisashi; Gardella, Thomas J.; Potts, Jr., John T., Nucleic acids encoding modified parathyroid hormone.
  255. Ni, Jian; Rosen, Craig A., Nucleic acids encoding tumor necrosis factor receptor TR10.
  256. Marchetti,Antonio; Buttitta,Fiamma; Smith,Gilbert H.; Callahan,Robert, Nucleotide and deduced amino acid sequences of tumor gene Int6.
  257. Kang, Eun Jung; Eom, Tae Gwan; Choi, Gyu Ok, Oligopeptide improving differentiation of osteoblasts.
  258. Roberts, Anthony; Kopsidas, George; Coia, Gregory; Sleigh, Merilyn; Batori, Vincent, Osteoprotegerin variant proteins.
  259. Roberts, Anthony; Kopsidas, George; Coia, Gregory; Sleigh, Merilyn; Batori, Vincent, Osteoprotegerin variant proteins.
  260. Goddard,Audrey; Godowski,Paul J.; Grimaldi,J. Christopher; Gurney,Austin L.; Wood,William I., PR0994 antibodies.
  261. Goddard,Audrey; Godowski,Paul J.; Gurney,Austin L.; Smith,Victoria; Watanabe,Colin K.; Wood,William I., PRO9822 antibodies.
  262. Goddard,Audrey; Godowski,Paul J.; Gurney,Austin L.; Smith,Victoria; Watanabe,Colin K.; Wood,William I., PRO9822 polypeptides.
  263. Goddard,Audrey; Godowski,Paul J.; Grimaldi,J. Christopher; Gurney,Austin L.; Wood,William I., PRO994 polypeptides.
  264. Reiter, Robert E.; Witte, Owen N., PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia.
  265. Reiter, Robert E.; Witte, Owen N., PSCA: prostate stem cell antigen and uses thereof.
  266. Reiter,Robert E.; Witte,Owen N.; Saffran,Douglas C.; Jakobovits,Aya, PSCA: prostate stem cell antigen and uses thereof in pancreatic cancer.
  267. Gardella, Thomas J.; Potts, Jr., John T.; Jueppner, Harald; Okazaki, Makoto, Parathyroid hormone analogs and uses thereof.
  268. Lundegaard, Claus; Christensen, Lars Harder; Wurtzen, Peter Adler; Sette, Alessandro; Sidney, John; Lund, Gitte; Andersen, Peter Sejer, Peptide combinations and uses thereof in treating dust mite allergy.
  269. Mori,Masaaki; Shimomura,Yukio; Harada,Mioko; Asami,Taiji; Matsumoto,Yoshio; Adachi,Yuka; Sugo,Tsukasa; Abe,Michiko; Goto,Mika; Kitada,Chieko; Watanabe,Takuya, Peptide having appetite stimulating activity.
  270. Chung, Yong Ji; Kim, Eun Mi; Lee, Eung Ji; Han, A Reum; Jung, Hyun A, Peptide having osteoblast proliferation activity and periodontal ligament fibroblast proliferation activity, and use of same.
  271. Papadopoulos,Vassilios; Culty,Martine, Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer.
  272. Sah, Dinah Wen-Yee; Pepinsky, R. Blake; Rossomando, Anthony, Polymer conjugated glycosylated neublastin.
  273. Sah, Dinah Wen-Yee; Pepinsky, R. Blake; Boriack-Sjodin, Paula Ann; Miller, Stephan S.; Rossomando, Anthony; Silvian, Laura, Polymer conjugates of mutated neublastin.
  274. Sah,Dinah Wen Yee; Pepinsky,R. Blake; Boriack Sjodin,Paula Ann; Miller,Stephan S.; Rossomando,Anthony; Silvian,Laura, Polymer conjugates of mutated neublastin.
  275. Sah, Dinah Wen-Yee; Pepinsky, R. Blake; Rossomando, Anthony, Polymer-conjugated glycosylated neublastin.
  276. Seehra, Jasbir, Polynucleotides encoding BMP-ALK3 antagonists.
  277. Parham, Christi L.; Moore, Kevin W.; Murgolo, Nicholas J., Polynucleotides encoding DIRS1.
  278. Ni,Jian; Yu,Guo Liang; Alfonso,Pedro; Gentz,Reiner; Su,Jeffrey Y., Polynucleotides encoding a human chemotactic cytokine I.
  279. Harari, Daniel; Yarden, Yosef, Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine.
  280. Shi, Yanggu; Ruben, Steven M., Polynucleotides encoding a novel interleukin receptor termed interleukin-17 receptor-like protein.
  281. Jian Ni ; Haodong Li ; Jeffrey Su, Polynucleotides encoding chemokine alpha-3.
  282. Harras,Marie; Donoho,Gregory; Turner, Jr.,C. Alexander; Nehls,Michael C.; Friedrich,Glenn; Zambrowicz,Brian; Sands,Arthur T., Polynucleotides encoding human transporter proteins.
  283. Ni,Jian; Rosen,Craig A.; Gentz,Reiner L., Polynucleotides encoding human tumor necrosis factor receptor-like2.
  284. Nabil Elshourbagy ; Usman Shabon ; Derk J. Bergsma, Polynucleotides encoding mouse urotensin-II Receptor (UTB-R).
  285. Lee,Ning; Chen,Jian; Wu,Shujian; Blanar,Michael A.; Levesque,Paul C.; Sun,Lucy, Polynucleotides encoding variants of the TRP channel family member, LTRPC3.
  286. Strachan, Lorna, Polynucleotides isolated from skin cells.
  287. Gardella, Thomas J.; Kronenberg, Henry M.; Potts, Jr., John T.; Juppner, Harald T., Polypeptide derivatives of parathyroid hormone (PTH).
  288. Kronenberg, Henry M.; Potts, Jr., John T.; Gardella, Thomas J., Polypeptide derivatives of parathyroid hormone (PTH).
  289. Nishikawa,Mitsuo, Polypeptide having an activity to support proliferation or survival of hematopoietic stem or progenitor cells.
  290. Pecker, Iris; Vlodavsky, Israel; Feinstein, Elena, Polypeptide having heparanase activity.
  291. Sebald,Walter, Polypeptide variants with increased heparin-binding capacity.
  292. Kieffer,Brigitte, Polypeptides having opioid receptor activity.
  293. Kieffer, Brigitte, Polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof.
  294. Evans Herbert J. ; Kini R. Manjunatha,SGX, Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site.
  295. Evans Herbert J. ; Kini R. Manjunatha,SGX, Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site.
  296. Evans Herbert J. ; Kini R. Manjunatha,SGX, Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site.
  297. Evans Herbert J. ; Kini R. Manjunatha,SGX, Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site.
  298. Evans Herbert J. ; Kini R. Manjunatha,SGX, Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site.
  299. Evans Herbert J. ; Kini R. Manjunatha,SGX, Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site.
  300. Evans Herbert J. ; Kini R. Manjunatha,SGX, Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site.
  301. Evans Herbert J. ; Kini R. Manjunatha,SGX, Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site.
  302. Goddard,Audrey; Godowski,Paul J.; Gurney,Austin L.; Pan,James; Watanabe,Colin K.; Wood,William I., Polypeptides that induce cell proliferation.
  303. Evans Herbert J. ; Kini R. Manjunatha,INX, Polypetides that include conformation-constraining groups which flank a protein-protein interaction site.
  304. Allan, Peter Stewart; Browne, Michael Andrew; Langeveld, Elfriede Maria; Lloyd, Paul; Manley, Reginald; Rennie, Paul Reissen; Stocker, Frederick Edmund; Tarverdi, Karnik; Thorpe, Jacqueline Marie, Process for the production of a deodorant or antiperspirant product.
  305. Kurth, Reinhard; Baier, Michael; Bannert, Norbert; Werner, Albrecht; Lang, Kurt, Processed polypeptides with IL-16 activity, process for preparing the same and their use.
  306. Bonini,James A.; Lerman,Gabriel S.; Ogozalek,Kristine L.; Quan,Yong, Processes for obtaining compounds employing SNORF72 receptors.
  307. Brines, Michael; Cerami, Anthony; Cerami, Carla, Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs.
  308. Takahashi, Yasuhiko; Matsumoto, Yasuo; Oeda, Kenji, Protein involved in G protein-coupled receptor mediated signal transduction with ability to mediate signal transduction from a dopamine D1 receptor or an adenosine A2A receptor to an adenylate cyclase and utilization thereof.
  309. Schneider-Fresenius, Christian; Otto, Bernd; Waschutza, Gero, Recombinant human beta interferon with enhanced solubility.
  310. Pfizenmaier, Klaus; Scheurich, Peter; Grunwald, Ingo; Krippner-Heidenreich, Anja, Recombinant polypeptides of the members of the TNF ligand family and use thereof.
  311. Medico, Enzo; Michieli, Paolo; Collesi, Chiara; Caselli, Gianfranco; Comoglio, Paolo, Recombinant proteins derived from HGF and MSP.
  312. Medico, Enzo; Michieli, Paolo; Colessi, Chiara; Caselli, Gianfranco; Comoglio, Paolo, Recombinant proteins from HGF and MSP.
  313. Rossomando, Anthony; Pepinsky, R. Blake; Gong, BangJian, Refolding transforming growth factor beta family proteins.
  314. Rossomando, Anthony; Pepinsky, R. Blake; Gong, BangJian, Refolding transforming growth factor beta family proteins.
  315. Lal,Preeti G.; Au Young,Janice; Reddy,Roopa; Murry,Lynn E.; Mathur,Preete, SP16 protein.
  316. Gardella, Thomas J.; Potts, Jr., John T.; Shimizu, Masaru; Ichikawa, Fumihiko; Juppner, Harald; Okazaki, Makoto, Screening methods using G-protein coupled receptors and related compositions.
  317. Gardella, Thomas J.; Potts, Jr., John T.; Shimizu, Masaru; Ichikawa, Fumihiko; Jüppner, Harald; Okazaki, Makoto, Screening methods using G-protein coupled receptors and related compositions.
  318. Cunningham, Brian C.; Wells, James A., Selecting ligand agonists and antagonists.
  319. Abellon, Rosario Perona; Pinilla, Rosario Machado; Garzon, Leandro Sastre; Perez, Isabel Sanchez; Ibanez, Jose Ramon Murguia, Sequence of nucleotides and peptides GSE 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof.
  320. Perona Abellon, Rosario; Machado Pinilla, Rosario; Sastre Garzon, Leandro; Sanchez Perez, Isabel; Murguia Ibanez, Jose Ramon, Sequence of nucleotides and peptides GSE 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof.
  321. Beyaert,Rudi; Janssens,Sophie, Splice variant of MyD88 and uses thereof.
  322. Tang,Y. Tom; Labat,Ivan; Drmanac,Radoje T.; Mize,Nancy K.; Nishikawa,Mitsuo; Chao,Cheng Chi, Stem cell growth factor-like polypeptides.
  323. Kieliszewski, Marcia J., Synthetic genes for plant gums and other hydroxyproline rich glycoproteins.
  324. Kieliszewski, Marcia J., Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins.
  325. Kieliszewski,Marcia J., Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins.
  326. Hauptmann,Rudolf; Himmler,Adolf; Maurer Fogy,Ingrid; Stratowa,Christian, TNF binding proteins.
  327. Itoh,Yasuaki; Nishi,Kazunori; Kitada,Chieko, Tachykinin-like polypeptides and use thereof.
  328. Fraser,Christopher C., Tango 243 polypeptides and uses thereof.
  329. Zhou, Bing; Zhou, Yu; Jiang, Jing, Therapeutic TRAIL fusion protein and preparation and use thereof.
  330. Clark Lewis,Ian; Gong,Jiang Hong; Duronio,Vincent, Therapeutic chemokine receptor antagonists.
  331. Clark-Lewis, Ian; Gong, Jiang-Hong; Duronio, Vincent; Salari, Hassan, Therapeutic chemokine receptor antagonists.
  332. Chung, Yong Hoon; Lee, Hak sup; Yi, Ki Wan; Heo, Youn Hwa; Kim, Jae Youn, Thrombopoietin protein variants.
  333. Brines, Michael; Cerami, Anthony; Cerami, Carla, Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs.
  334. Brines, Michael; Cerami, Anthony; Coleman, Thomas; Yilmaz, Osman, Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions.
  335. Adams, Camellia W.; Ashkenazi, Avi J.; Chuntharapai, Anan; Kim, Kyung Jin, Treatment of cancer using anti-Apo-2 antibodies.
  336. Hedlund, Gunnar; Forsberg, Göran; Wallén-öhman, Marie, Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent.
  337. Hedlund, Gunnar; Forsberg, Göran; Wallén-öhman, Marie, Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent.
  338. Gospodarowicz, Denis J.; Masiarz, Frank R., Truncated keratinocyte growth factor (KGF) having increased biological activity.
  339. Gorodeski, George; Feng, Ying-Hong; Li, Xin, Truncated proteins as cancer markers.
  340. Gorodeski, George; Feng, Ying-Hong; Li, Xin, Truncated proteins as cancer markers.
  341. Fisher,Eric F.; Edwards, III,Carl K.; Kieft,Gary L., Truncated soluble tumor necrosis factor type-I and type-II receptors.
  342. Gentz,Reiner L.; Ebner,Reinhard; Yu,Guo Liang; Ruben,Steven M.; Ni,Jian; Feng,Ping, Tumor necrosis factor 6α and 6β.
  343. Gentz, Reiner L.; Ebner, Reinhard; Yu, Guo-Liang; Ruben, Steven M.; Ni, Jian; Feng, Ping, Tumor necrosis factor receptors 6α and 6β.
  344. Lee, Tae Ho; Wisniewski, Hans-Georg; Vilcek, Jan, Tumor necrosis factor stimulated gene 6 (TSG-6) protein.
  345. Deen, Keith Charles; Hurle, Mark R.; Young, Peter; Tan, Kong B., Tumor necrosis related receptor, TR7.
  346. Deen,Keith Charles; Hurle,Mark R.; Young,Peter; Tan,Kong B., Tumor necrosis related receptor, TR7.
  347. Yu, Guo-Liang; Ni, Jian; Gentz, Reiner L.; Dillon, Patrick J., Use of DR3 antibodies in the treatment of inflammatory disease.
  348. Shih, Shou-Chuan; Tsao, Yeou-Ping; Ho, Tsung-Chuan, Use of PEDF-derived polypeptides for treating liver cirrhosis.
  349. Carmeliet,Peter; Collen,D?sir?; Oosthuyse,Bert, Use of VEGF and homologues to treat neuron disorders.
  350. Ni, Jian; Rosen, Craig A.; Gentz, Reiner L., Use of an antibody that binds human tumor necrosis factor receptor-like 2.
  351. Paulista,Michael; Pohl,Jens, Use of cytokines of the TGF-β superfamily for the treatment, inhibition and/or diagnosis of skin related disorders.
  352. Vargas Luis A.,CLX ; Faerman Carlos H. ; Karplus P. Andrew, Use of human transferrin in controlling insulin levels.
  353. Vargas Luis A.,CLX ; Faerman Carlos H. ; Karplus P. Andrew, Use of human transferrin in controlling insulin levels.
  354. Kokaia, Merab; Woldbye, David, Use of nucleic acid sequences for the treatment of epilepsy.
  355. Goldspink, Geoffrey; Goldspink, Paul, Use of the insulin-like-growth factor 1 splice variant MGF for the prevention of myocardial damage.
  356. Wells James A. ; Cunningham Brian C., Variants of human prolactin and human placeatal lactogen.
  357. Cunningham, Brian C.; Wells, James A., Variants of native growth hormones having non naturally occurring amino acid sequences or covalent modifications.
  358. Guo, Mei; Rupe, Mary A; Bruce, Wesley B; Gupta, Rajeev; Simmons, Carl R, Zea maize auxin response related genes for controlling plant growth and organ size and their use in improving crop plants.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로